Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 405-800-7 | CAS number: 27955-94-8 THPE; TRIS(P-HYDROXYPHENYL)ETHANE; TRIS(PARA-HYDROXYPHENYL)ETHANE
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Remarks:
- The study was conducted prior to the current OECD 476 guideline. The study design does not include a continuous exposure.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 994
- Report date:
- 1994
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- yes
- Remarks:
- The study design does not include a continuous exposure.
- GLP compliance:
- yes
- Type of assay:
- mammalian cell gene mutation assay
Test material
- Reference substance name:
- 4,4',4''-(ethan-1,1,1-triyl)triphenol
- EC Number:
- 405-800-7
- EC Name:
- 4,4',4''-(ethan-1,1,1-triyl)triphenol
- Cas Number:
- 27955-94-8
- Molecular formula:
- C20H18O3
- IUPAC Name:
- 4-[1,1-bis(4-hydroxyphenyl)ethyl]phenol
- Details on test material:
- - Purity: >99+%
Constituent 1
Method
- Target gene:
- thymidine kinase locus
Species / strain
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Details on mammalian cell type (if applicable):
- - Type and identity of media: RMPI 1640, supplemented with 0.1% Synperonic F68, 0.011% sodium pyruvate, 2 mM L-glutamine, 50 µg/mL gentamicin and buffered with 2 mg/mL sodium bicarbonate, is referred to as R0p. A variation buffered with HEPES called R0 (HEPES) was also used. A third media used was R0p supplemented with 10% HiDHS and referred to as R10p. R10p from which growing L5178Y cells had been removed was used as conditioned medium. R0 (HEPES) containing 5% HiDHS, designated R5 (HEPES), was used as the treatment medium. R0p in which the amount of Synperonic F68 had been reduced to 0.02% and supplemented with 30% HiDHS, referred to as R30p, formed the basis of the cloning medium. This was semi-solidified by the addition of Noble agar to a final concentration of approximately 0.4%. Selective medium consisted of cloning medium containing 4 µg/mL TFT.
- Periodically "cleansed" against high spontaneous background: yes
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor 1254-induced Sprague-Dawley rat liver homogenate (S-9)
- Test concentrations with justification for top dose:
- With and without activation, Test 1: 0, 0.5, 1, 2.5, 5, 7.5, 10, 15, 20, and 25 µg/m
With and without activation, Test 2: 0, 5, 10, 15, 20, 30, 40, 50, 60, and 80 µg/m - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: Dimethylsulfoxide
- Justification for choice of solvent/vehicle: The maximum solubility of the test substance was 393.8 mg/mL.
Controls
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- 200 µL added to each culture
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: Ethyl methane sulphonate was used without activation, and 20-methylcholanthrene was used with activation
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in suspension
DURATION
- Exposure duration: 3 hours
- Expression time (cells in growth medium): 48 hours after the 3 hour treatment period
NUMBER OF REPLICATIONS: 2
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth - Evaluation criteria:
- The criteria for a positive response were:
At least a 2-fold increase in mutant frequency in treated cultures relative to the control
Demonstration of a statistically significant increase in mutant frequency following treatment with the test substance
Evidence of a dose relationship over at least 2 dose levels, in any increase in mutant frequency
Demonstration of reproducibility in any increase in mutant frequency
The observed increases in mutant frequency must lie outside the upper limit of the historical control range, 150 mutants per 10E6 survivors. - Statistics:
- The statistical significance of the data was analysed by weighted analysis of variance following the methods described by Arlett et al. (1989)
Results and discussion
Test results
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- RANGE-FINDING/SCREENING STUDIES: In the range-finding study, treatment with 1-200 µg/mL in the absence and presence of S-9 mix resulted in relative growth in suspension of 70-2% and 89-2% respectively compared to the solvent controls. Concentrations used in the main test were based upon this data.
COMPARISON WITH HISTORICAL CONTROL DATA: There were no increases in mutant frequency outside the upper limit of the historical control range, 150 mutants per 10E6 survivors.
Applicant's summary and conclusion
- Conclusions:
- The test substance did not demonstrate mutagenic potential in this in vitro gene mutation assay.
- Executive summary:
The test substance was tested for mutagenic potential in an in vitro mammalian cell mutation assay. This test system is based on detection and quantitation of forward mutation in a subline of mouse lymphoma L5178Y cells, from the heterozygous condition at the thymidine kinase locus (TK+/-) to the thymidine kinase deficient genotype (TK-/-). Two independent tests in the absence of exogenous metabolic activation (S-9 mix) and two independent tests in the presence of S-9 mix were carried out. Toxicity was observed after treatment with the test substance in all the tests both in the absence and the presence of S-9 mix. No biologically significant increases in mutant frequency, according to the criteria used for a positive response, were observed after treatment with the test substance either in the absence or the presence of S-9 mix. Decreases in mutant colony size in comparison with the controls were not observed in any of the tests. It was concluded that the test substance did not demonstrate mutagenic potential in this in vitro mammalian cell mutation assay.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)